Detalhe da pesquisa
1.
Long-term outcomes with HLX01 (HanliKang®), a rituximab biosimilar, in previously untreated patients with diffuse large B-cell lymphoma: 5-year follow-up results of the phase 3 HLX01-NHL03 study.
BMC Cancer
; 24(1): 124, 2024 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38267866
2.
Dual epigenetic agents plus rituximab-gemcitabine-oxaliplatin as salvage treatment in relapsed/refractory diffuse large B-cell lymphoma patients failure of salvage chemotherapy.
Hematol Oncol
; 40(5): 914-921, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35856472
3.
Epstein-Barr virus and cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation in patients with non-Hodgkin lymphoma: the prevalence and impacts on outcomes : EBV and CMV reactivation post allo-HCT in NHL.
Ann Hematol
; 100(11): 2773-2785, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34480615
4.
Excellent Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Paroxysmal Nocturnal Hemoglobinuria: A Single-Center Study.
Biol Blood Marrow Transplant
; 25(8): 1544-1549, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30853571
5.
Modified BuCy is an alternative conditioning regimen for lymphoma patients undergoing autologous stem cell transplantation.
Ann Hematol
; 98(5): 1259-1266, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30635767
6.
HLA-mismatched stem cell microtransplantation compared to matched-sibling donor transplantation for intermediate/high-risk acute myeloid leukemia.
Ann Hematol
; 98(5): 1249-1257, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30631895
7.
Acute liver failure associated with human adenovirus infection after allogeneic hematopoietic stem cell transplantation.
Ann Hematol
; 102(8): 2287-2289, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37178390
8.
Outcome of Allogeneic and Autologous Hematopoietic Cell Transplantation for High-Risk Peripheral T Cell Lymphomas: A Retrospective Analysis From a Chinese Center.
Biol Blood Marrow Transplant
; 23(8): 1393-1397, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28478121
9.
High expression of myocyte enhancer factor 2C predicts poor prognosis for adult acute myeloid leukaemia with normal karyotype.
Br J Haematol
; 189(1): e23-e27, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32017034
10.
[Therapeutic efficacies of decitabine application prior to hematopoietic cell transplantation in patients with myelodysplastic syndrome and acute myeloid leukemia].
Zhonghua Yi Xue Za Zhi
; 95(12): 920-4, 2015 Mar 31.
Artigo
em Zh
| MEDLINE | ID: mdl-26081055
11.
Extramedullary relapse of acute leukemia after allogeneic hematopoietic stem cell transplantation: different characteristics between acute myelogenous leukemia and acute lymphoblastic leukemia.
Biol Blood Marrow Transplant
; 20(7): 1040-7, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24704575
12.
Donor origin CAR19 T cell infusion for B-ALL relapsed after allogeneic hematopoietic stem cell transplantation.
Hematol Oncol
; 37(5): 655-658, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31656047
13.
[Efficacies of hematopoietic stem cell transplantation for severe aplastic anemia: a report of 43 patients].
Zhonghua Yi Xue Za Zhi
; 94(40): 3140-4, 2014 Nov 04.
Artigo
em Zh
| MEDLINE | ID: mdl-25573308
14.
Outcomes of allogeneic hematopoietic stem cell transplantation in R/R DLBCL patients with failure of CAR-T therapy.
Exp Hematol Oncol
; 13(1): 4, 2024 Jan 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38229150
15.
Comparison of valganciclovir versus foscarnet for the treatment of cytomegalovirus viremia in adult acute leukemia patients after allogeneic hematopoietic cell transplantation.
Leuk Lymphoma
; 65(6): 816-824, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38475670
16.
Enhancer of Zeste Homolog 2 Inhibitor SHR2554 in Relapsed or Refractory Peripheral T-cell Lymphoma: Data from the First-in-Human Phase I Study.
Clin Cancer Res
; 30(7): 1248-1255, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38190117
17.
[Impact of induced therapy before allogeneic hematopoietic stem-cell transplantation for higher-risk myelodysplastic syndrome: experience of single centre].
Zhonghua Yi Xue Za Zhi
; 93(40): 3185-8, 2013 Oct 29.
Artigo
em Zh
| MEDLINE | ID: mdl-24405537
18.
[Retrospective analysis on therapeutic effect of autologous hematopoietic stem cell transplantation in multiple myeloma patients].
Zhonghua Yi Xue Za Zhi
; 93(2): 114-8, 2013 Jan 08.
Artigo
em Zh
| MEDLINE | ID: mdl-23648347
19.
[Lower risk myelodysplastic syndrome patients with transfusion dependent treated by dose-reduced decitabine].
Zhonghua Yi Xue Za Zhi
; 93(40): 3189-92, 2013 Oct 29.
Artigo
em Zh
| MEDLINE | ID: mdl-24405538
20.
Body mass index-associated responses to an ABVD-like regimen in newly-diagnosed patients with Hodgkin lymphoma.
Front Pharmacol
; 14: 1195907, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37680722